I’ll be connecting with more startup people here soon. I’ve got a project I’m deeply passionate about, and I’d love for us to build on it together. Right now, I’m focused on growing and building genuine connections first.
One of the hardest prayers is:
“God, if this isn’t for me, give me the strength to let it go.”
Because sometimes we don’t actually want God’s will.
We want God to bless our plan.
And when He starts redirecting us, we call it disappointment.
Maybe some closed doors are answers too.
Seven people just got arrested in Accra for turning real Ghana cedi notes into money bouquets and money cakes.
Not fake notes. Genuine currency, folded into gifts and sold for weddings, birthdays and graduations.
We need the law here in Nigeria. 🇳🇬
8,679 West African startups entered. One walked out with $30,000. Tope Kareem, co-founder and CEO of HubPharm Africa, just won the ECOWAS Startup Awards for a pharmacy that gets medicine to chronic-care patients across Nigeria.
Would you put a robot in your parents kitchen if it could catch a fall and call you before you found out the next morning? Rhem Labs is selling one for countertop use. Vitals, radar fall detection, and it can book the doctor or refill the prescription.
The robot industry is getting crazy.
China has a company called UBTECH building humanoid robots with robots helping build the robots.
Its new factory in Liuzhou is designed to produce 1 humanoid robot every 10 minutes. That’s more than 10,000 robots a year.
We’re entering a different era.
She cut the feet off her pantyhose with scissors. That crazy idea became Spanx.
Sara Blakely had $5,000, no fashion experience, and investors laughing at her.
She kept building.
Today, Spanx became a billion-dollar empire.
He sold $112,000 of ad space on his own body.
For a HYROX race in Turkey, Marc Lou auctioned temporary logos across his chest, back, arms, and legs.
About a dozen companies paid up. He’d already built 36+ startups. This one was just him.
VAXICAN recently raised $2.9M to advance an AI-powered platform for developing cancer vaccines, targeting diseases including HER2-positive breast cancer and neuroblastoma.